Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- NatureWise Biotech & Medicals Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT03808870
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer
- First Posted Date
- 2018-10-31
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- NatureWise Biotech & Medicals Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT03726294
- Locations
- 🇺🇸
NEXT Oncology, San Antonio, Texas, United States
News
No news found